Skip to Content

Bio-Techne Corp TECH

Morningstar Rating
$79.39 −1.40 (1.73%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TECH is trading at a 454% premium.
Price
$81.09
Fair Value
$91.53
Uncertainty
High
1-Star Price
$968.17
5-Star Price
$29.83
Economic Moat
Ymzsppb
Capital Allocation
Wwfztcr
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TECH is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$80.79
Day Range
$79.0480.93
52-Week Range
$51.7989.91
Bid/Ask
$77.60 / $81.15
Market Cap
$12.51 Bil
Volume/Avg
795,261 / 1.1 Mil

Key Statistics

Price/Earnings (Normalized)
43.15
Price/Sales
11.08
Dividend Yield (Trailing)
0.40%
Dividend Yield (Forward)
0.40%
Total Yield
1.02%

Company Profile

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Mid Core
Total Number of Employees
3,050

Comparables

Valuation

Metric
TECH
TIHE
BIO
Price/Earnings (Normalized)
43.1523.88
Price/Book Value
6.210.90
Price/Sales
11.083.18
Price/Cash Flow
40.2812.08
Price/Earnings
TECH
TIHE
BIO

Financial Strength

Metric
TECH
TIHE
BIO
Quick Ratio
2.494.48
Current Ratio
4.086.57
Interest Coverage
14.52−9.70
Quick Ratio
TECH
TIHE
BIO

Profitability

Metric
TECH
TIHE
BIO
Return on Assets (Normalized)
10.95%2.73%
Return on Equity (Normalized)
14.98%3.84%
Return on Invested Capital (Normalized)
12.39%2.95%
Return on Assets
TECH
TIHE
BIO
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRZcrlnpzytFdjl$593.7 Bil
VRTX
Vertex Pharmaceuticals IncTxcgrljrBnbmn$115.3 Bil
REGN
Regeneron Pharmaceuticals IncScwznjpjBgykj$108.5 Bil
MRNA
Moderna IncQcwlkbmcBnyhs$63.9 Bil
BNTX
BioNTech SE ADRPphbfctxhYnqwx$23.4 Bil
ARGX
argenx SE ADRPpkbgmgbDgpdw$22.1 Bil
ALNY
Alnylam Pharmaceuticals IncCzsbnhyyCscdvmh$19.0 Bil
BMRN
Biomarin Pharmaceutical IncVyxkjqmMcndk$14.3 Bil
INCY
Incyte CorpDnkyrvchGbsgrb$12.9 Bil
UTHR
United Therapeutics CorpHxtbvkvpZlqp$12.1 Bil

Sponsor Center